perampanel and Asthma

perampanel has been researched along with Asthma* in 1 studies

Other Studies

1 other study(ies) available for perampanel and Asthma

Article	Year
[A case of the successful treatment of severe myoclonus with Lance-Adams syndrome by add-on perampanel showing long term effects]. Rinsho shinkeigaku = Clinical neurology, 2021, Jan-29, Volume: 61, Issue:1 Perampanel is an α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist that has been marked as an antiepileptic drug for partial-onset and primary generalized tonic-clonic seizures. There have been some recent reports of perampanel being effective against cortical myoclonus by Lafora disease and Unverricht-Lundborg disease. We herein report a 49-year-old man who presented with myoclonus due to Lance-Adams syndrome (LAS) after cardiopulmonary arrest caused by a severe bronchial asthma attack. Perampanel was very effective against myoclonus induced by LAS even in the chronic state, over 10 years after the remote onset. Perampanel should be considered for the treatment of extremely refractory myoclonus due to LAS. Topics: Anticonvulsants; Asthma; Heart Arrest; Humans; Lafora Disease; Male; Middle Aged; Myoclonus; Nitriles; Pyridones; Receptors, AMPA; Severity of Illness Index; Treatment Outcome; Unverricht-Lundborg Syndrome	2021

Article

Year

[A case of the successful treatment of severe myoclonus with Lance-Adams syndrome by add-on perampanel showing long term effects].

Rinsho shinkeigaku = Clinical neurology, 2021, Jan-29, Volume: 61, Issue:1

Perampanel is an α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist that has been marked as an antiepileptic drug for partial-onset and primary generalized tonic-clonic seizures. There have been some recent reports of perampanel being effective against cortical myoclonus by Lafora disease and Unverricht-Lundborg disease. We herein report a 49-year-old man who presented with myoclonus due to Lance-Adams syndrome (LAS) after cardiopulmonary arrest caused by a severe bronchial asthma attack. Perampanel was very effective against myoclonus induced by LAS even in the chronic state, over 10 years after the remote onset. Perampanel should be considered for the treatment of extremely refractory myoclonus due to LAS.

Topics: Anticonvulsants; Asthma; Heart Arrest; Humans; Lafora Disease; Male; Middle Aged; Myoclonus; Nitriles; Pyridones; Receptors, AMPA; Severity of Illness Index; Treatment Outcome; Unverricht-Lundborg Syndrome

2021